NYSE: CGAU
Centerra Gold Inc Stock Forecast, Predictions & Price Target

Analyst price target for CGAU

Based on 1 analyst offering 12 month price targets for Centerra Gold Inc

Min Forecast
$19.00-2.36%
Avg Forecast
$19.00-2.36%
Max Forecast
$19.00-2.36%

Should I buy or sell CGAU stock?

Based on 1 analyst offering ratings for Centerra Gold Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Strong Buy" agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their CGAU stock forecasts and price targets.

CGAU stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-26Find Out Why

1 of 1

CGAU vs Gold Stocks

TickerPricePrice TargetUp/downsideConsensus
CGAU$19.46$19.00-2.36%Buy
AAUC$31.53N/AN/A
NG$9.48$13.26+39.87%Strong Buy
ARIS$20.74N/AN/A
HYMC$37.50N/AN/A

Centerra Gold Stock Forecast FAQ

Is Centerra Gold Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: CGAU) stock is to Buy CGAU stock.

Out of 1 analyst, 0 (0%) are recommending CGAU as a Strong Buy, 1 (100%) are recommending CGAU as a Buy, 0 (0%) are recommending CGAU as a Hold, 0 (0%) are recommending CGAU as a Sell, and 0 (0%) are recommending CGAU as a Strong Sell.

If you're new to stock investing, here's how to buy Centerra Gold stock.

What is CGAU's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CGAU price target, the average CGAU price target is $19.00, with the highest CGAU stock price forecast at $19.00 and the lowest CGAU stock price forecast at $19.00.

The Wall Street analyst predicted that Centerra Gold's share price could fall to $19.00 by Jan 26, 2027. The average Centerra Gold stock price prediction forecasts a potential downside of 2.36% from the current CGAU share price of $19.46.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.